China ha completado el ensayo preclínico de su primer sistema de ultrasonido focalizado guiado por resonancia magnética ( #MRgFUS ) de desarrollo propio. La prueba realizada en macacos rhesus demostró ser segura, eficaz y estable en el tratamiento del temblor esencial y de la enfermedad con predominio de temblor #Parkinson (PD) .
China has completed the preclinical trial of its first self-developed magnetic resonance-guided focused ultrasound (#MRgFUS) system. The test on rhesus macaque proved safe, effective and stable in treating essential tremor and tremor-predominant #Parkinson's disease (PD).
China has completed the preclinical trial of its first self-developed magnetic resonance-guided focused ultrasound (#MRgFUS) system. The test on rhesus macaque proved safe, effective and stable in treating essential tremor and tremor-predominant #Parkinson's disease (PD). pic.twitter.com/AMyGMlAKVE
— China Science (@ChinaScience) April 29, 2024
.jpeg)
